Targeting BCMA in Multiple Myeloma: Evidence-Based Guidance for Current and Near-Future Clinical Integration

Download All
Learn how experts apply practice-changing clinical data to integrate the use of BCMA-targeted agents for their patients with multiple myeloma, with focused commentaries, a healthcare professional resource, and a module with downloadable slides.
Nina Shah, MD

Module

Read this module from Nina Shah, MD, to learn more about how BCMA-targeted agents work in multiple myeloma and how you can use these agents in clinical practice to improve patient outcomes.

Nina Shah, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: April 4, 2022 Expired: April 3, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Pfizer, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings